Clinical Study of a Personalized Neoantigen Cancer Vaccine in Treating Patients With Advanced Malignant Tumor
Conditions
- Advanced Malignant Solid Tumor
Interventions
- BIOLOGICAL: iNeo-Vac-P01
- OTHER: GM-CSF
Sponsor
Sir Run Run Shaw Hospital
Collaborators